| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.386 | 0.003 | 0.666 | Dopamine transporter inhibitor | 0.666 0.002 DB06701 0.579 0.002 DBMET03284 0.513 0.002 DBMET00651 0.584 0.002 DBMET02408 0.553 0.002 DBMET02407 0.41 0.003 DBMET03282 0.439 0.003 DBMET03283 | DB06701 | |
| 0.284 | 0.055 | 0.284 | Angiogenesis stimulant | 0.143 0.127 DBMET00651 0.182 0.104 DBMET02407 0.141 0.129 DBMET03282 0.199 0.095 DBMET03283 | ||
| 0.183 | 0.06 | 0.238 | Thrombolytic | 0.175 0.065 DB06701 0.174 0.065 DBMET03284 0.238 0.037 DBMET00651 0.124 0.106 DBMET02408 0.183 0.06 DBMET02407 0.189 0.057 DBMET03282 0.23 0.039 DBMET03283 | DBMET00651 | |
| 0.2 | 0.08 | 0.865 | Psychostimulant | 0.809 0.004 DB06701 0.865 0.003 DBMET03284 0.708 0.004 DBMET00651 0.828 0.004 DBMET02408 0.78 0.004 DBMET02407 0.731 0.004 DBMET03282 0.682 0.005 DBMET03283 | DBMET03284 | |
| 0.23 | 0.132 | 0.23 | Immunomodulator | |||
| 0.148 | 0.083 | 0.186 | Anticoagulant | 0.186 0.059 DB06701 0.176 0.063 DBMET03284 0.176 0.063 DBMET00651 0.159 0.073 DBMET02408 0.155 0.076 DBMET02407 0.152 0.079 DBMET03282 0.149 0.081 DBMET03283 | DB06701 | |
| 0.155 | 0.101 | 0.161 | Platelet adhesion inhibitor | 0.141 0.117 DB06701 0.134 0.126 DBMET03284 0.161 0.095 DBMET02407 0.145 0.111 DBMET03283 | DBMET02407 | |
| 0.064 | 0.027 | 0.064 | Elastase inhibitor | |||
| 0.216 | 0.18 | 0.516 | Immunosuppressant | 0.376 0.074 DB06701 0.377 0.073 DBMET03284 0.502 0.032 DBMET00651 0.398 0.064 DBMET02408 0.381 0.072 DBMET02407 0.516 0.029 DBMET03282 0.487 0.037 DBMET03283 | DBMET03282 | |
| 0.071 | 0.045 | 0.071 | Elastase 1 inhibitor | |||
| 0.167 | 0.141 | 0.294 | Immunostimulant | 0.184 0.131 DB06701 0.224 0.107 DBMET03284 0.234 0.103 DBMET00651 0.241 0.1 DBMET02408 0.231 0.104 DBMET02407 0.294 0.08 DBMET03282 0.26 0.092 DBMET03283 | DBMET03282 | |
| 0.166 | 0.155 | 0.18 | Peptidyltransferase inhibitor | 0.164 0.16 DBMET03282 0.18 0.128 DBMET03283 | DBMET03283 | |
| 0.08 | 0.072 | 0.14 | Hematopoietic | 0.084 0.061 DBMET00651 0.094 0.042 DBMET02408 0.14 0.017 DBMET03282 0.081 0.07 DBMET03283 | DBMET03282 | |
| 0.038 | 0.032 | 0.038 | Integrin alpha5beta1 antagonist | 0.036 0.035 DBMET00651 | ||
| 0.093 | 0.088 | 0.116 | Nav1.4 sodium channel blocker | 0.092 0.089 DBMET00651 0.116 0.056 DBMET03282 0.108 0.065 DBMET03283 | DBMET03282 | |
| 0.231 | 0.228 | 0.579 | Calcium channel L-type activator | 0.507 0.025 DB06701 0.487 0.033 DBMET03284 0.475 0.038 DBMET00651 0.579 0.008 DBMET02408 0.523 0.02 DBMET02407 0.561 0.011 DBMET03282 0.494 0.03 DBMET03283 | DBMET02408 | |
| 0.097 | 0.096 | 0.097 | Cell adhesion inhibitor | 0.097 0.096 DBMET03282 | ||
| 0.017 | 0.017 | 0.026 | Integrin alphaVbeta1 antagonist | 0.026 0.007 DBMET00651 0.023 0.009 DBMET03283 | DBMET00651 | |
| 0.03 | 0.033 | 0.031 | ADAM10 endopeptidase inhibitor | 0.031 0.03 DB06701 0.031 0.028 DBMET00651 | DBMET00651 | |
| 0.048 | 0.052 | 0.055 | Angiotensin-converting enzyme inhibitor | 0.055 0.038 DBMET00651 0.052 0.043 DBMET03282 0.052 0.043 DBMET03283 | DBMET00651 | |
| 0.044 | 0.048 | 0.071 | Prolyl endopeptidase inhibitor | 0.067 0.017 DB06701 0.071 0.015 DBMET03284 0.07 0.015 DBMET00651 0.065 0.019 DBMET02408 0.052 0.033 DBMET02407 0.068 0.017 DBMET03282 0.06 0.024 DBMET03283 | DBMET03284 | |
| 0.016 | 0.026 | 0.11 | VLA-4 antagonist | 0.085 0.007 DBMET00651 0.11 0.005 DBMET03282 0.068 0.009 DBMET03283 | DBMET03282 | |
| 0.094 | 0.105 | 0.32 | Cholinergic antagonist | 0.256 0.02 DB06701 0.32 0.013 DBMET03284 0.197 0.033 DBMET00651 0.161 0.047 DBMET02408 0.241 0.023 DBMET02407 0.122 0.072 DBMET03282 0.188 0.035 DBMET03283 | DBMET03284 | |
| 0.186 | 0.2 | 0.239 | Apoptosis antagonist | 0.193 0.189 DBMET00651 0.231 0.146 DBMET02407 0.204 0.173 DBMET03282 0.239 0.139 DBMET03283 | DBMET03283 | |
| 0.014 | 0.032 | 0.093 | Integrin alpha4 antagonist | 0.053 0.011 DBMET00651 0.093 0.007 DBMET03282 0.03 0.016 DBMET03283 | DBMET03282 | |
| 0.025 | 0.043 | 0.12 | Integrin antagonist | 0.116 0.014 DBMET00651 0.12 0.013 DBMET03282 0.07 0.022 DBMET03283 | DBMET03282 | |
| 0.015 | 0.034 | 0.021 | Aminopeptidase P inhibitor | 0.021 0.019 DBMET00651 | DBMET00651 | |
| 0.18 | 0.2 | 0.592 | Vasodilator, peripheral | 0.505 0.027 DB06701 0.476 0.033 DBMET03284 0.387 0.059 DBMET00651 0.592 0.017 DBMET02408 0.514 0.025 DBMET02407 0.459 0.038 DBMET03282 0.378 0.063 DBMET03283 | DBMET02408 | |
| 0.046 | 0.068 | 0.539 | Adrenaline uptake inhibitor | 0.539 0.003 DB06701 0.475 0.003 DBMET03284 0.452 0.004 DBMET00651 0.394 0.004 DBMET02408 0.426 0.004 DBMET02407 0.29 0.004 DBMET03282 0.369 0.004 DBMET03283 | DB06701 | |
| 0.004 | 0.028 | 0.011 | Integrin alphaVbeta5 antagonist | 0.011 0.006 DBMET00651 | DBMET00651 | |
| 0.064 | 0.088 | 0.081 | Chymotrypsin inhibitor | 0.072 0.066 DB06701 0.072 0.068 DBMET03284 0.081 0.053 DBMET02408 0.077 0.058 DBMET03282 | DBMET02408 | |
| 0.006 | 0.032 | 0.04 | Integrin alpha4beta1 antagonist | 0.021 0.009 DBMET00651 0.04 0.006 DBMET03282 0.014 0.012 DBMET03283 | DBMET03282 | |
| 0.046 | 0.072 | 0.067 | Cathepsin E inhibitor | 0.067 0.032 DB06701 0.065 0.034 DBMET00651 0.058 0.043 DBMET02408 0.061 0.039 DBMET02407 0.056 0.047 DBMET03282 0.059 0.042 DBMET03283 | DB06701 | |
| 0.05 | 0.078 | 0.061 | Caspase 9 inhibitor | 0.061 0.046 DBMET00651 0.059 0.05 DBMET03282 | DBMET00651 | |
| 0.027 | 0.067 | 0.074 | Glutamate (mGluR8) antagonist | 0.053 0.007 DB06701 0.049 0.009 DBMET03284 0.074 0.004 DBMET00651 0.05 0.009 DBMET02408 0.05 0.009 DBMET02407 0.07 0.004 DBMET03282 0.064 0.005 DBMET03283 | DBMET00651 | |
| 0.077 | 0.125 | 0.14 | Toll-Like receptor 4 antagonist | 0.123 0.041 DB06701 0.12 0.044 DBMET02408 0.14 0.027 DBMET02407 | DBMET02407 | |
| 0.045 | 0.097 | 0.061 | Gonadotropin-releasing hormone receptor agonist | 0.061 0.038 DBMET02408 0.056 0.048 DBMET03282 | DBMET02408 | |
| 0.006 | 0.059 | 0.027 | Endothelin B receptor antagonist | 0.018 0.014 DB06701 0.027 0.009 DBMET02408 | DBMET02408 | |
| 0.01 | 0.066 | 0.02 | Integrin beta5 antagonist | 0.02 0.015 DBMET00651 0.02 0.015 DBMET03282 | DBMET03282 | |
| 0.047 | 0.109 | 0.076 | Heme oxygenase stimulant | 0.073 0.021 DB06701 0.065 0.034 DBMET03284 0.075 0.019 DBMET00651 0.069 0.026 DBMET02408 0.076 0.018 DBMET02407 0.071 0.023 DBMET03282 0.076 0.018 DBMET03283 | DBMET03283 | |
| 0.029 | 0.099 | 0.572 | Dopamine uptake inhibitor | 0.572 0.003 DB06701 0.383 0.004 DBMET03284 0.222 0.005 DBMET00651 0.158 0.009 DBMET02408 0.438 0.003 DBMET02407 0.054 0.045 DBMET03282 0.177 0.008 DBMET03283 | DB06701 | |
| 0.009 | 0.09 | 0.025 | Endothelin receptor antagonist | 0.025 0.023 DBMET02408 | DBMET02408 | |
| 0.011 | 0.093 | 0.044 | Melanocortin 5 antagonist | 0.025 0.019 DB06701 0.023 0.022 DBMET03284 0.03 0.015 DBMET00651 0.033 0.014 DBMET02408 0.044 0.012 DBMET03282 0.023 0.021 DBMET03283 | DBMET03282 | |
| 0.024 | 0.106 | 0.039 | Neurotensin receptor antagonist | 0.039 0.038 DBMET03283 | DBMET03283 | |
| 0.029 | 0.122 | 0.064 | HCV NS3/NS4A protease inhibitor | 0.048 0.036 DB06701 0.054 0.027 DBMET00651 0.056 0.024 DBMET02408 0.064 0.018 DBMET03282 | DBMET03282 | |
| 0.106 | 0.21 | 0.193 | Platelet antagonist | 0.163 0.132 DBMET00651 0.15 0.144 DBMET02408 0.193 0.106 DBMET03282 | DBMET03282 | |
| 0.018 | 0.127 | 0.058 | Melanocortin antagonist | 0.046 0.034 DB06701 0.042 0.04 DBMET03284 0.048 0.032 DBMET00651 0.056 0.023 DBMET02408 0.058 0.022 DBMET03282 | DBMET03282 | |
| 0.02 | 0.131 | 0.616 | 5 Hydroxytryptamine uptake inhibitor | 0.616 0.004 DB06701 0.55 0.004 DBMET03284 0.478 0.004 DBMET00651 0.457 0.004 DBMET02408 0.486 0.004 DBMET02407 0.275 0.007 DBMET03282 0.388 0.005 DBMET03283 | DB06701 | |
| 0.026 | 0.138 | 0.049 | DNA gyrase subunit A inhibitor | 0.049 0.018 DBMET02408 0.043 0.028 DBMET03282 | DBMET02408 | |
| 0.018 | 0.132 | 0.028 | Vasopressin 1A agonist | 0.028 0.02 DBMET03282 | DBMET03282 | |
| 0.12 | 0.235 | 0.173 | Hypoglycemic | 0.173 0.143 DBMET03283 | DBMET03283 | |
| 0.011 | 0.128 | 0.022 | Vasopressin 1 agonist | 0.022 0.015 DBMET03282 | DBMET03282 | |
| 0.026 | 0.143 | 0.037 | Integrin alpha1beta1 antagonist | 0.037 0.031 DBMET00651 | DBMET00651 | |
| 0.06 | 0.178 | 0.141 | Mucolytic | 0.109 0.066 DB06701 0.124 0.05 DBMET03284 0.13 0.046 DBMET00651 0.108 0.068 DBMET02408 0.134 0.043 DBMET02407 0.128 0.047 DBMET03282 0.141 0.038 DBMET03283 | DBMET03283 | |
| 0.019 | 0.137 | 0.055 | Plasminogen activator inhibitor | 0.055 0.043 DBMET00651 0.051 0.047 DBMET03283 | DBMET00651 | |
| 0.03 | 0.155 | 0.063 | Bombesin 1 receptor agonist | 0.063 0.038 DBMET02408 0.062 0.039 DBMET03282 | DBMET02408 | |
| 0.082 | 0.21 | 0.469 | Sigma receptor agonist | 0.469 0.013 DB06701 0.381 0.025 DBMET03284 0.437 0.017 DBMET00651 0.446 0.015 DBMET02408 0.442 0.016 DBMET02407 0.411 0.02 DBMET03282 0.429 0.018 DBMET03283 | DB06701 | |
| 0.004 | 0.139 | 0.013 | Integrin alphaVbeta6 antagonist | 0.013 0.012 DBMET00651 | DBMET00651 | |
| 0.073 | 0.21 | 0.156 | Neurotrophic factor | 0.145 0.064 DB06701 0.148 0.061 DBMET03284 0.156 0.054 DBMET00651 0.116 0.102 DBMET02408 0.142 0.067 DBMET02407 0.124 0.088 DBMET03282 0.15 0.059 DBMET03283 | DBMET00651 | |
| 0.012 | 0.152 | 0.028 | Antidiuretic hormone agonist | 0.026 0.022 DBMET02408 0.028 0.018 DBMET03282 | DBMET03282 | |
| 0.022 | 0.163 | 0.044 | Baculoviral IAP repeat-containing protein inhibitor | 0.044 0.04 DB06701 0.044 0.041 DBMET00651 | DBMET00651 | |
| 0.036 | 0.178 | 0.098 | Calcium channel L-type blocker | 0.077 0.043 DB06701 0.098 0.025 DBMET03284 | DBMET03284 | |
| 0.04 | 0.183 | 0.096 | Opioid antagonist | 0.09 0.057 DBMET02407 0.096 0.05 DBMET03283 | DBMET03283 | |
| 0.035 | 0.179 | 0.144 | Acetylcholine M3 receptor agonist | 0.101 0.044 DB06701 0.144 0.022 DBMET03284 0.076 0.064 DBMET00651 0.127 0.031 DBMET02408 0.102 0.044 DBMET03282 | DBMET03284 | |
| 0.022 | 0.175 | 0.036 | Glucose-6-phosphate dehydrogenase inhibitor | 0.036 0.031 DBMET00651 0.036 0.03 DBMET03283 | DBMET03283 | |
| 0.052 | 0.211 | 0.115 | Proteasome inhibitor | 0.115 0.07 DBMET02408 0.098 0.09 DBMET03282 | DBMET02408 | |
| 0.018 | 0.179 | 0.07 | Opioid mu receptor antagonist | 0.059 0.055 DBMET02407 0.07 0.046 DBMET03283 | DBMET03283 | |
| 0.053 | 0.215 | 0.123 | Bone formation stimulant | 0.123 0.083 DBMET03283 | DBMET03283 | |
| 0.127 | 0.29 | 0.382 | Antithrombotic | 0.302 0.086 DB06701 0.364 0.06 DBMET03284 0.36 0.061 DBMET00651 0.32 0.077 DBMET02408 0.325 0.074 DBMET02407 0.382 0.054 DBMET03282 0.36 0.061 DBMET03283 | DBMET03282 | |
| 0.015 | 0.178 | 0.038 | Growth hormone release inhibitor | 0.038 0.035 DBMET03282 | DBMET03282 | |
| 0.032 | 0.199 | 0.082 | Analgesic, opioid | 0.079 0.048 DBMET02407 0.082 0.045 DBMET03283 | DBMET03283 | |
| 0.05 | 0.22 | 0.301 | Acetylcholine antagonist | 0.249 0.02 DB06701 0.301 0.014 DBMET03284 0.189 0.034 DBMET00651 0.155 0.047 DBMET02408 0.234 0.023 DBMET02407 0.117 0.073 DBMET03282 0.182 0.036 DBMET03283 | DBMET03284 | |
| 0.005 | 0.176 | 0.039 | Leukotriene A4 hydrolase inhibitor | 0.039 0.026 DBMET00651 | DBMET00651 | |
| 0.148 | 0.322 | 0.262 | Ca(v)3.3 blocker | 0.262 0.083 DB06701 0.257 0.09 DBMET03284 0.242 0.113 DBMET00651 0.22 0.152 DBMET02408 0.202 0.189 DBMET02407 0.203 0.185 DBMET03283 | DB06701 | |
| 0.015 | 0.193 | 0.064 | Opioid delta receptor antagonist | 0.064 0.043 DBMET03283 | DBMET03283 | |
| 0.13 | 0.309 | 0.297 | Sodium/bile acid cotransporter inhibitor | 0.232 0.148 DBMET00651 0.228 0.153 DBMET02407 0.281 0.097 DBMET03282 0.297 0.082 DBMET03283 | DBMET03283 | |
| 0.056 | 0.238 | 0.078 | 3C-Like protease (SARS coronavirus) inhibitor | 0.078 0.075 DBMET03284 | DBMET03284 | |
| 0.039 | 0.225 | 0.078 | Opioid kappa receptor antagonist | 0.078 0.061 DBMET02407 0.078 0.06 DBMET03283 | DBMET03283 | |
| 0.061 | 0.249 | 0.161 | Histone deacetylase SIRT1 inhibitor | 0.126 0.084 DBMET02408 0.161 0.053 DBMET03282 | DBMET03282 | |
| 0.01 | 0.2 | 0.04 | Oxytocin antagonist | 0.04 0.024 DBMET02408 | DBMET02408 | |
| 0.025 | 0.217 | 0.273 | Acetylcholine nicotinic antagonist | 0.259 0.009 DB06701 0.273 0.008 DBMET03284 0.164 0.017 DBMET00651 0.128 0.027 DBMET02408 0.199 0.013 DBMET02407 0.079 0.055 DBMET03282 0.148 0.021 DBMET03283 | DBMET03284 | |
| 0.052 | 0.247 | 0.13 | Microtubule formation inhibitor | 0.105 0.083 DB06701 0.111 0.073 DBMET03284 0.107 0.079 DBMET00651 0.126 0.054 DBMET02408 0.103 0.085 DBMET02407 0.13 0.051 DBMET03282 0.101 0.089 DBMET03283 | DBMET03282 | |
| 0.138 | 0.333 | 0.477 | Interleukin 2 agonist | 0.218 0.16 DB06701 0.234 0.137 DBMET03284 0.325 0.058 DBMET00651 0.407 0.025 DBMET02408 0.26 0.108 DBMET02407 0.477 0.011 DBMET03282 0.332 0.054 DBMET03283 | DBMET03282 | |
| 0.01 | 0.208 | 0.029 | Calcitonin receptor agonist | 0.029 0.028 DBMET03283 | DBMET03283 | |
| 0.007 | 0.21 | 0.028 | Prostaglandin D2 agonist | 0.028 0.025 DBMET03282 | DBMET03282 | |
| 0.012 | 0.217 | 0.026 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.026 0.021 DBMET00651 0.026 0.023 DBMET03282 0.026 0.021 DBMET03283 | DBMET03283 | |
| 0.01 | 0.215 | 0.039 | Nicotinic receptor beta4 subunit antagonist | 0.033 0.032 DB06701 0.039 0.023 DBMET00651 0.039 0.024 DBMET03283 | DBMET03283 | |
| 0.033 | 0.243 | 0.165 | Expectorant | 0.117 0.053 DB06701 0.133 0.043 DBMET03284 0.144 0.038 DBMET00651 0.154 0.034 DBMET02407 0.101 0.067 DBMET03282 0.165 0.03 DBMET03283 | DBMET03283 | |
| 0.009 | 0.22 | 0.038 | Melanocortin 4 antagonist | 0.038 0.034 DBMET03282 | DBMET03282 | |
| 0.046 | 0.257 | 0.123 | Calcium channel (voltage-sensitive) blocker | 0.114 0.064 DB06701 0.123 0.054 DBMET03284 | DBMET03284 | |
| 0.025 | 0.237 | 0.139 | Aminopeptidase I inhibitor | 0.069 0.055 DB06701 0.078 0.044 DBMET03284 0.139 0.014 DBMET00651 0.065 0.061 DBMET02407 0.114 0.022 DBMET03282 0.12 0.019 DBMET03283 | DBMET00651 | |
| 0.042 | 0.255 | 0.24 | Acetylcholine muscarinic antagonist | 0.19 0.027 DB06701 0.24 0.016 DBMET03284 0.156 0.04 DBMET00651 0.129 0.059 DBMET02408 0.186 0.028 DBMET02407 0.106 0.083 DBMET03282 0.153 0.042 DBMET03283 | DBMET03284 | |
| 0.025 | 0.241 | 0.138 | Cathepsin G inhibitor | 0.1 0.033 DB06701 0.072 0.051 DBMET03284 0.103 0.032 DBMET00651 0.135 0.024 DBMET02408 0.096 0.035 DBMET02407 0.138 0.023 DBMET03282 0.096 0.035 DBMET03283 | DBMET03282 | |
| 0.01 | 0.228 | 0.04 | Somatostatin 1 antagonist | 0.04 0.026 DBMET03282 | DBMET03282 | |
| 0.057 | 0.276 | 0.119 | Interleukin 8 antagonist | 0.116 0.067 DBMET00651 0.119 0.063 DBMET03283 | DBMET03283 | |
| 0.04 | 0.262 | 0.064 | Prolactin release inhibitor | 0.059 0.057 DB06701 0.064 0.038 DBMET00651 0.061 0.05 DBMET02407 0.064 0.036 DBMET03283 | DBMET03283 | |
| 0.043 | 0.269 | 0.1 | Caspase 3 inhibitor | 0.1 0.091 DBMET00651 | DBMET00651 | |
| 0.094 | 0.322 | 0.227 | Neurotensin receptor agonist | 0.174 0.056 DB06701 0.17 0.062 DBMET03284 0.198 0.035 DBMET00651 0.194 0.038 DBMET02408 0.202 0.034 DBMET02407 0.224 0.026 DBMET03282 0.227 0.025 DBMET03283 | DBMET03283 | |
| 0.014 | 0.247 | 0.034 | Cholecystokinin B agonist | 0.034 0.031 DBMET03282 | DBMET03282 | |
| 0.017 | 0.252 | 0.079 | Catalase inhibitor | 0.079 0.048 DBMET03282 | DBMET03282 | |
| 0.006 | 0.241 | 0.052 | Lysine carboxypeptidase inhibitor | 0.052 0.007 DBMET00651 0.037 0.012 DBMET03282 0.043 0.009 DBMET03283 | DBMET00651 | |
| 0.015 | 0.251 | 0.073 | Nicotinic receptor alpha4 subunit antagonist | 0.073 0.015 DB06701 0.063 0.02 DBMET03284 0.069 0.017 DBMET00651 0.056 0.025 DBMET02407 0.059 0.023 DBMET03283 | DB06701 | |
| 0.049 | 0.289 | 0.18 | Toll-Like receptor 2 antagonist | 0.125 0.073 DB06701 0.128 0.07 DBMET03284 0.123 0.075 DBMET00651 0.18 0.034 DBMET02407 0.164 0.044 DBMET03283 | DBMET02407 | |
| 0.028 | 0.271 | 0.095 | Ca(v)2.2 blocker | 0.081 0.064 DB06701 0.095 0.052 DBMET03284 0.083 0.063 DBMET00651 | DBMET03284 | |
| 0.008 | 0.257 | 0.02 | Tryptophan hydroxylase 1 inhibitor | 0.02 0.007 DBMET00651 0.017 0.012 DBMET03283 | DBMET00651 | |
| 0.067 | 0.324 | 0.128 | Growth hormone agonist | 0.128 0.11 DBMET03283 | DBMET03283 | |
| 0.046 | 0.308 | 0.178 | Calcium channel blocker | 0.156 0.054 DB06701 0.178 0.04 DBMET03284 | DBMET03284 | |
| 0.048 | 0.313 | 0.267 | Acetylcholine M1 receptor antagonist | 0.228 0.032 DB06701 0.267 0.021 DBMET03284 0.199 0.043 DBMET00651 0.143 0.081 DBMET02408 0.224 0.033 DBMET02407 0.122 0.105 DBMET03282 0.197 0.044 DBMET03283 | DBMET03284 | |
| 0.014 | 0.285 | 0.138 | Neuronal nicotinic receptor antagonist | 0.138 0.014 DB06701 0.115 0.019 DBMET03284 0.099 0.025 DBMET00651 0.068 0.046 DBMET02408 0.11 0.02 DBMET02407 0.09 0.029 DBMET03283 | DB06701 | |
| 0.057 | 0.33 | 0.132 | Nitric oxide antagonist | 0.132 0.116 DBMET02407 | DBMET02407 | |
| 0.006 | 0.29 | 0.014 | Integrin beta6 antagonist | 0.014 0.01 DBMET03283 | DBMET03283 | |
| 0.064 | 0.352 | 0.25 | Vasodilator | 0.225 0.086 DB06701 0.246 0.071 DBMET03284 0.25 0.069 DBMET02408 0.245 0.072 DBMET02407 | DBMET02408 | |
| 0.065 | 0.36 | 0.258 | Antioxidant | 0.178 0.134 DBMET02407 0.258 0.08 DBMET03283 | DBMET03283 | |
| 0.097 | 0.397 | 0.375 | Insulysin inhibitor | 0.356 0.032 DB06701 0.325 0.045 DBMET03284 0.37 0.028 DBMET00651 0.351 0.034 DBMET02408 0.367 0.029 DBMET02407 0.365 0.029 DBMET03282 0.375 0.027 DBMET03283 | DBMET03283 | |
| 0.025 | 0.328 | 0.102 | Somatostatin 1 agonist | 0.079 0.053 DBMET02408 0.102 0.032 DBMET03282 0.072 0.061 DBMET03283 | DBMET03282 | |
| 0.016 | 0.326 | 0.469 | Anesthetic local | 0.302 0.012 DB06701 0.469 0.005 DBMET03284 0.192 0.034 DBMET00651 0.149 0.049 DBMET02408 0.267 0.017 DBMET02407 0.164 0.043 DBMET03283 | DBMET03284 | |
| 0.01 | 0.321 | 0.062 | Nicotinic receptor alpha7 subunit antagonist | 0.061 0.028 DB06701 0.054 0.036 DBMET03284 0.062 0.027 DBMET00651 0.054 0.036 DBMET03283 | DBMET00651 | |
| 0.013 | 0.33 | 0.165 | Alpha-mannosidase inhibitor | 0.095 0.007 DB06701 0.087 0.009 DBMET03284 0.165 0.004 DBMET00651 0.066 0.02 DBMET02408 0.094 0.007 DBMET02407 0.094 0.007 DBMET03282 0.13 0.004 DBMET03283 | DBMET00651 | |
| 0.028 | 0.346 | 0.17 | Sphingomyelinase inhibitor | 0.134 0.032 DB06701 0.17 0.017 DBMET03284 0.116 0.044 DBMET00651 0.114 0.046 DBMET02407 0.092 0.069 DBMET03283 | DBMET03284 | |
| 0.061 | 0.381 | 0.194 | Tumour necrosis factor antagonist | 0.133 0.122 DB06701 0.194 0.057 DBMET02408 | DBMET02408 | |
| 0.031 | 0.375 | 0.124 | Lipid peroxidase inhibitor | 0.121 0.093 DBMET02407 0.124 0.09 DBMET03283 | DBMET03283 | |
| 0.014 | 0.377 | 0.058 | CXC chemokine 4 receptor antagonist | 0.058 0.044 DBMET00651 0.055 0.047 DBMET03283 | DBMET00651 | |
| 0.007 | 0.375 | 0.068 | Acetylcholine M2 receptor antagonist | 0.053 0.051 DB06701 0.068 0.038 DBMET03284 | DBMET03284 | |
| 0.009 | 0.382 | 0.054 | Nicotinic receptor alpha3 subunit antagonist | 0.051 0.024 DB06701 0.041 0.034 DBMET03284 0.054 0.022 DBMET00651 0.043 0.031 DBMET03283 | DBMET00651 | |
| 0.077 | 0.451 | 0.156 | Catenin beta inhibitor | 0.147 0.112 DBMET02407 0.156 0.093 DBMET03283 | DBMET03283 | |
| 0.033 | 0.409 | 0.098 | Granulocyte macrophage colony stimulating factor agonist | 0.094 0.044 DB06701 0.092 0.048 DBMET03284 0.098 0.038 DBMET02408 0.091 0.049 DBMET02407 | DBMET02408 | |
| 0.042 | 0.418 | 0.191 | Free radical scavenger | 0.191 0.105 DBMET02407 0.174 0.12 DBMET03283 | DBMET02407 | |
| 0.036 | 0.414 | 0.149 | Nav1.1 sodium channel blocker | 0.115 0.052 DB06701 0.109 0.057 DBMET03284 0.135 0.04 DBMET00651 0.128 0.043 DBMET02408 0.114 0.052 DBMET02407 0.149 0.033 DBMET03282 0.131 0.041 DBMET03283 | DBMET03282 | |
| 0.009 | 0.39 | 0.053 | Membrane dipeptidase inhibitor | 0.053 0.014 DBMET00651 0.052 0.014 DBMET03282 0.037 0.031 DBMET03283 | DBMET00651 | |
| 0.008 | 0.393 | 0.151 | Mannosidase inhibitor | 0.078 0.009 DB06701 0.073 0.011 DBMET03284 0.151 0.004 DBMET00651 0.054 0.021 DBMET02408 0.078 0.009 DBMET02407 0.089 0.007 DBMET03282 0.118 0.005 DBMET03283 | DBMET00651 | |
| 0.004 | 0.402 | 0.015 | Somatostatin 2 agonist | 0.014 0.01 DB06701 0.015 0.01 DBMET00651 0.014 0.011 DBMET02407 0.015 0.009 DBMET03283 | DBMET03283 | |
| 0.048 | 0.446 | 0.183 | Melanin inhibitor | 0.132 0.11 DB06701 0.143 0.091 DBMET00651 0.155 0.076 DBMET02408 0.182 0.05 DBMET02407 0.167 0.062 DBMET03282 0.183 0.049 DBMET03283 | DBMET03283 | |
| 0.008 | 0.408 | 0.119 | Dopamine agonist | 0.106 0.025 DB06701 0.091 0.031 DBMET03284 0.065 0.048 DBMET00651 0.118 0.021 DBMET02408 0.119 0.02 DBMET02407 0.077 0.039 DBMET03282 0.087 0.033 DBMET03283 | DBMET02407 | |
| 0.036 | 0.453 | 0.251 | Calpain inhibitor | 0.172 0.146 DB06701 0.202 0.112 DBMET03284 0.251 0.064 DBMET02408 0.237 0.078 DBMET03282 | DBMET02408 | |
| 0.052 | 0.471 | 0.132 | Vanilloid 1 agonist | 0.112 0.108 DB06701 0.131 0.064 DBMET03284 0.121 0.085 DBMET00651 0.114 0.104 DBMET02408 0.127 0.071 DBMET02407 0.123 0.081 DBMET03282 0.132 0.062 DBMET03283 | DBMET03283 | |
| 0.015 | 0.44 | 0.094 | Protease 3C (Human rhinovirus) inhibitor | 0.062 0.049 DB06701 0.094 0.018 DBMET03284 0.072 0.035 DBMET02408 0.059 0.053 DBMET03282 | DBMET03284 | |
| 0.005 | 0.432 | 0.096 | Acetylcholine M3 receptor antagonist | 0.08 0.026 DB06701 0.094 0.02 DBMET03284 0.073 0.03 DBMET00651 0.096 0.019 DBMET02407 0.085 0.024 DBMET03283 | DBMET02407 | |
| 0.005 | 0.437 | 0.07 | GABA uptake inhibitor | 0.037 0.031 DB06701 0.051 0.015 DBMET03284 0.07 0.007 DBMET00651 0.049 0.016 DBMET03283 | DBMET00651 | |
| 0.03 | 0.463 | 0.631 | Spasmolytic | 0.447 0.031 DB06701 0.631 0.01 DBMET03284 0.358 0.05 DBMET00651 0.376 0.045 DBMET02408 0.481 0.026 DBMET02407 0.299 0.07 DBMET03282 0.374 0.046 DBMET03283 | DBMET03284 | |
| 0.026 | 0.472 | 0.214 | Protein kinase stimulant | 0.159 0.062 DB06701 0.134 0.08 DBMET03284 0.148 0.069 DBMET00651 0.155 0.065 DBMET02408 0.214 0.037 DBMET02407 0.144 0.072 DBMET03282 0.18 0.05 DBMET03283 | DBMET02407 | |
| 0.037 | 0.487 | 0.135 | Insulin secretagoues | 0.135 0.09 DBMET00651 0.124 0.105 DBMET03282 0.135 0.091 DBMET03283 | DBMET03283 | |
| 0.004 | 0.455 | 0.028 | Epoxide hydrolase 1 inhibitor | 0.028 0.027 DB06701 | DB06701 | |
| 0.019 | 0.471 | 0.098 | Interleukin 1 beta converting enzyme inhibitor | 0.098 0.059 DBMET03282 | DBMET03282 | |
| 0.04 | 0.496 | 0.218 | DNA synthesis inhibitor | 0.174 0.163 DBMET03284 0.213 0.104 DBMET00651 0.172 0.166 DBMET02408 0.194 0.132 DBMET02407 0.215 0.101 DBMET03282 0.218 0.097 DBMET03283 | DBMET03283 | |
| 0.005 | 0.466 | 0.057 | Acetylcholine muscarinic agonist | 0.057 0.036 DBMET03284 | DBMET03284 | |
| 0.008 | 0.474 | 0.036 | Cyclophilin A inhibitor | 0.033 0.019 DBMET02408 0.036 0.015 DBMET03282 | DBMET03282 | |
| 0.008 | 0.483 | 0.149 | Nicotinic alpha4beta2 receptor antagonist | 0.149 0.008 DB06701 0.137 0.011 DBMET03284 0.142 0.01 DBMET00651 0.113 0.022 DBMET02407 0.117 0.019 DBMET03283 | DB06701 | |
| 0.024 | 0.502 | 0.113 | Calcium channel N-type blocker | 0.105 0.086 DB06701 0.113 0.072 DBMET03284 | DBMET03284 | |
| 0.002 | 0.48 | 0.064 | Arginase inhibitor | 0.064 0.009 DBMET00651 0.034 0.027 DBMET02407 0.035 0.026 DBMET03282 0.061 0.01 DBMET03283 | DBMET00651 | |
| 0.006 | 0.486 | 0.035 | Integrin alpha2beta1 antagonist | 0.029 0.014 DBMET00651 0.035 0.009 DBMET03282 | DBMET03282 | |
| 0.016 | 0.503 | 0.064 | Ryanodine receptor antagonist | 0.058 0.044 DB06701 0.055 0.054 DBMET02408 0.064 0.028 DBMET02407 | DBMET02407 | |
| 0.003 | 0.49 | 0.031 | Carnitine palmitoyltransferase 1 inhibitor | 0.031 0.029 DBMET00651 | DBMET00651 | |
| 0.012 | 0.504 | 0.067 | Phospholipase D inhibitor | 0.067 0.06 DBMET00651 | DBMET00651 | |
| 0.006 | 0.503 | 0.118 | Glutamate (mGluR1) agonist | 0.03 0.01 DB06701 0.054 0.004 DBMET03284 0.118 0.003 DBMET00651 0.023 0.021 DBMET02408 0.025 0.016 DBMET02407 0.064 0.004 DBMET03282 0.073 0.004 DBMET03283 | DBMET00651 | |
| 0.053 | 0.549 | 0.383 | Toll-Like receptor agonist | 0.383 0.067 DBMET00651 0.322 0.098 DBMET03282 0.342 0.086 DBMET03283 | DBMET00651 | |
| 0.007 | 0.506 | 0.05 | Integrin alpha2 antagonist | 0.038 0.023 DBMET03284 0.05 0.011 DBMET00651 0.048 0.013 DBMET03282 0.034 0.031 DBMET03283 | DBMET00651 | |
| 0.034 | 0.534 | 0.1 | Estrogen-related receptor beta agonist | 0.08 0.068 DBMET02408 0.1 0.025 DBMET02407 0.085 0.053 DBMET03283 | DBMET02407 | |
| 0.013 | 0.516 | 0.073 | Potassium channel (Tandem pore domain) blocker | 0.073 0.055 DBMET03284 | DBMET03284 | |
| 0.021 | 0.527 | 0.256 | Anticonvulsant | 0.179 0.099 DB06701 0.256 0.055 DBMET03284 | DBMET03284 | |
| 0.006 | 0.518 | 0.057 | Oxytocin agonist | 0.039 0.033 DBMET00651 0.042 0.03 DBMET02408 0.038 0.034 DBMET02407 0.057 0.019 DBMET03282 0.053 0.022 DBMET03283 | DBMET03282 | |
| 0.009 | 0.527 | 0.141 | Leukotriene synthesis inhibitor | 0.137 0.012 DBMET00651 0.068 0.046 DBMET02407 0.121 0.016 DBMET03282 0.141 0.011 DBMET03283 | DBMET03283 | |
| 0.003 | 0.522 | 0.096 | Glutamate (mGluR1a) agonist | 0.024 0.013 DB06701 0.022 0.016 DBMET03284 0.096 0.004 DBMET00651 0.022 0.016 DBMET02408 0.08 0.004 DBMET03282 0.05 0.005 DBMET03283 | DBMET00651 | |
| 0.006 | 0.525 | 0.086 | Histamine H1 receptor antagonist | 0.086 0.052 DBMET03284 | DBMET03284 | |
| 0.019 | 0.542 | 0.308 | Alpha-N-acetylglucosaminidase inhibitor | 0.12 0.078 DB06701 0.16 0.05 DBMET03284 0.308 0.015 DBMET00651 0.115 0.083 DBMET02408 0.105 0.094 DBMET02407 0.296 0.017 DBMET03282 0.228 0.027 DBMET03283 | DBMET00651 | |
| 0.008 | 0.532 | 0.125 | Histamine antagonist | 0.125 0.037 DBMET03284 | DBMET03284 | |
| 0.002 | 0.53 | 0.016 | Nicotinic alpha4 receptor agonist | 0.016 0.011 DB06701 | DB06701 | |
| 0.023 | 0.556 | 0.089 | Alpha 2d adrenoreceptor antagonist | 0.089 0.072 DB06701 | DB06701 | |
| 0.01 | 0.544 | 0.137 | Antihistaminic | 0.082 0.074 DB06701 0.137 0.036 DBMET03284 | DBMET03284 | |
| 0.016 | 0.55 | 0.092 | Histamine H2 receptor antagonist | 0.092 0.044 DBMET03284 | DBMET03284 | |
| 0.017 | 0.553 | 0.046 | Antiviral (Hepatitis D) | 0.046 0.045 DBMET02408 | DBMET02408 | |
| 0.004 | 0.546 | 0.036 | Angiotensin II receptor antagonist | 0.036 0.02 DBMET03282 | DBMET03282 | |
| 0.031 | 0.577 | 0.239 | Transcription factor NF kappa B inhibitor | 0.215 0.155 DBMET02408 0.239 0.135 DBMET02407 0.206 0.163 DBMET03282 0.209 0.16 DBMET03283 | DBMET02407 | |
| 0.009 | 0.57 | 0.07 | Phenylethanolamine N methyltransferase inhibitor | 0.065 0.005 DB06701 0.061 0.007 DBMET03284 0.07 0.005 DBMET00651 0.059 0.008 DBMET02407 0.064 0.006 DBMET03283 | DBMET00651 | |
| 0.024 | 0.589 | 0.353 | Antiamyloidogenic | 0.258 0.068 DB06701 0.164 0.129 DBMET03284 0.156 0.14 DBMET00651 0.172 0.121 DBMET02408 0.353 0.038 DBMET02407 0.213 0.091 DBMET03283 | DBMET02407 | |
| 0.02 | 0.586 | 0.157 | Acetylcholine release stimulant | 0.146 0.019 DB06701 0.156 0.013 DBMET03284 0.11 0.066 DBMET00651 0.157 0.013 DBMET02408 0.116 0.056 DBMET02407 0.12 0.049 DBMET03282 | DBMET02408 | |
| 0.004 | 0.571 | 0.04 | Thyroid hormone agonist | 0.024 0.023 DBMET02408 0.04 0.006 DBMET03282 0.029 0.014 DBMET03283 | DBMET03282 | |
| 0.007 | 0.578 | 0.068 | Tryptophan 5 hydroxylase inhibitor | 0.045 0.009 DB06701 0.05 0.005 DBMET03284 0.068 0.003 DBMET00651 0.035 0.027 DBMET02408 0.036 0.025 DBMET02407 0.052 0.005 DBMET03282 0.05 0.005 DBMET03283 | DBMET00651 | |
| 0.015 | 0.589 | 0.195 | Aminopeptidase B inhibitor | 0.132 0.046 DBMET03284 0.168 0.031 DBMET00651 0.096 0.068 DBMET02408 0.195 0.023 DBMET03282 0.152 0.037 DBMET03283 | DBMET03282 | |
| 0.002 | 0.577 | 0.033 | Nicotinic alpha4beta2 receptor agonist | 0.033 0.014 DB06701 0.028 0.02 DBMET03284 0.027 0.022 DBMET00651 | DB06701 | |
| 0.013 | 0.594 | 0.103 | Nicotinic alpha3beta2 receptor antagonist | 0.103 0.007 DB06701 0.081 0.012 DBMET03284 0.093 0.009 DBMET00651 0.067 0.019 DBMET02407 0.063 0.023 DBMET03283 | DB06701 | |
| 0.007 | 0.597 | 0.094 | Acetylcholine agonist | 0.094 0.051 DBMET03284 | DBMET03284 | |
| 0.038 | 0.63 | 0.382 | Toll-Like receptor 7 agonist | 0.382 0.067 DBMET00651 0.325 0.095 DBMET03282 0.344 0.085 DBMET03283 | DBMET00651 | |
| 0.006 | 0.601 | 0.2 | Adrenaline agonist | 0.129 0.021 DB06701 0.151 0.014 DBMET03284 0.15 0.014 DBMET00651 0.076 0.063 DBMET02408 0.194 0.007 DBMET02407 0.091 0.045 DBMET03282 0.2 0.007 DBMET03283 | DBMET03283 | |
| 0.005 | 0.604 | 0.068 | Dihydroorotase inhibitor | 0.051 0.023 DB06701 0.068 0.012 DBMET03284 0.06 0.016 DBMET00651 0.041 0.036 DBMET02407 0.045 0.03 DBMET03282 0.043 0.033 DBMET03283 | DBMET03284 | |
| 0.005 | 0.605 | 0.036 | Histone deacetylase 9 inhibitor | 0.036 0.035 DBMET03282 | DBMET03282 | |
| 0.008 | 0.611 | 0.076 | Kainate receptor agonist | 0.046 0.019 DB06701 0.04 0.033 DBMET03284 0.076 0.004 DBMET00651 0.046 0.019 DBMET02408 0.044 0.023 DBMET02407 0.076 0.004 DBMET03282 0.065 0.005 DBMET03283 | DBMET03282 | |
| 0.005 | 0.608 | 0.035 | Carboxypeptidase B inhibitor | 0.035 0.02 DBMET00651 0.032 0.026 DBMET03282 | DBMET00651 | |
| 0.008 | 0.616 | 0.115 | NMDA receptor agonist | 0.067 0.039 DB06701 0.115 0.015 DBMET00651 0.058 0.05 DBMET02407 0.09 0.024 DBMET03282 0.083 0.027 DBMET03283 | DBMET00651 | |
| 0.016 | 0.625 | 0.116 | Glutamate (mGluR6) antagonist | 0.081 0.023 DB06701 0.102 0.01 DBMET03284 0.116 0.006 DBMET00651 0.08 0.024 DBMET02408 0.071 0.037 DBMET02407 0.114 0.006 DBMET03282 0.093 0.014 DBMET03283 | DBMET00651 | |
| 0.004 | 0.614 | 0.026 | AMPA 2 receptor antagonist | 0.026 0.024 DBMET00651 | DBMET00651 | |
| 0.019 | 0.629 | 0.106 | MAP kinase kinase 7 inhibitor | 0.073 0.072 DB06701 0.089 0.026 DBMET00651 0.093 0.02 DBMET02407 0.106 0.008 DBMET03283 | DBMET03283 | |
| 0.06 | 0.674 | 0.577 | Tyrosine 3 hydroxylase inhibitor | 0.343 0.018 DB06701 0.472 0.004 DBMET03284 0.472 0.004 DBMET00651 0.233 0.086 DBMET02408 0.425 0.006 DBMET02407 0.32 0.025 DBMET03282 0.577 0.003 DBMET03283 | DBMET03283 | |
| 0.005 | 0.621 | 0.047 | Glutamate (mGluR3) agonist | 0.043 0.008 DBMET00651 0.034 0.018 DBMET02407 0.038 0.012 DBMET03282 0.047 0.006 DBMET03283 | DBMET03283 | |
| 0.004 | 0.623 | 0.051 | Sphingosine kinase 1 inhibitor | 0.051 0.015 DBMET00651 0.048 0.019 DBMET03283 | DBMET00651 | |
| 0.005 | 0.625 | 0.08 | Sphingosine kinase inhibitor | 0.057 0.046 DBMET03284 0.078 0.018 DBMET00651 0.06 0.039 DBMET02407 0.08 0.016 DBMET03283 | DBMET03283 | |
| 0.006 | 0.627 | 0.066 | Aconitate hydratase inhibitor | 0.066 0.021 DBMET00651 0.066 0.021 DBMET03282 | DBMET03282 | |
| 0.058 | 0.681 | 0.413 | Caspase 9 stimulant | 0.335 0.159 DB06701 0.282 0.214 DBMET00651 0.413 0.103 DBMET02408 0.404 0.109 DBMET02407 0.35 0.145 DBMET03282 0.333 0.16 DBMET03283 | DBMET02408 | |
| 0.011 | 0.635 | 0.061 | Transcription factor AP-1 inhibitor | 0.061 0.044 DBMET03284 | DBMET03284 | |
| 0.013 | 0.639 | 0.18 | Prolactin inhibitor | 0.099 0.057 DB06701 0.091 0.066 DBMET03284 0.154 0.02 DBMET00651 0.127 0.034 DBMET02407 0.093 0.063 DBMET03282 0.18 0.013 DBMET03283 | DBMET03283 | |
| 0.003 | 0.631 | 0.045 | Angiotensin AT1 receptor antagonist | 0.045 0.025 DBMET03282 | DBMET03282 | |
| 0.036 | 0.665 | 0.453 | Vasodilator, coronary | 0.363 0.049 DB06701 0.453 0.023 DBMET03284 0.359 0.051 DBMET00651 0.353 0.054 DBMET02408 0.371 0.046 DBMET02407 0.35 0.055 DBMET03282 0.363 0.049 DBMET03283 | DBMET03284 | |
| 0.005 | 0.635 | 0.056 | Calcium channel T-type blocker | 0.056 0.044 DB06701 | DB06701 | |
| 0.005 | 0.643 | 0.048 | Beta adrenoreceptor agonist | 0.046 0.03 DBMET02407 0.048 0.021 DBMET03283 | DBMET03283 | |
| 0.018 | 0.657 | 0.145 | Nav1.3 sodium channel blocker | 0.145 0.051 DB06701 0.133 0.061 DBMET03284 0.141 0.054 DBMET00651 0.1 0.097 DBMET02407 0.106 0.09 DBMET03283 | DB06701 | |
| 0.003 | 0.644 | 0.023 | 5-Alpha-reductase 2 inhibitor | 0.023 0.011 DBMET03282 | DBMET03282 | |
| 0.062 | 0.706 | 0.181 | Nitric-oxide synthase stimulant | 0.173 0.146 DBMET02408 0.177 0.135 DBMET02407 0.179 0.131 DBMET03282 0.181 0.125 DBMET03283 | DBMET03283 | |
| 0.028 | 0.673 | 0.21 | Neuropeptide Y2 antagonist | 0.178 0.165 DB06701 0.2 0.119 DBMET03284 0.205 0.111 DBMET00651 0.183 0.154 DBMET02408 0.21 0.103 DBMET03282 0.204 0.112 DBMET03283 | DBMET03282 | |
| 0.006 | 0.651 | 0.172 | Acetylcholine M4 receptor antagonist | 0.143 0.012 DB06701 0.172 0.008 DBMET03284 0.092 0.035 DBMET00651 0.097 0.031 DBMET02408 0.091 0.036 DBMET02407 | DBMET03284 | |
| 0.005 | 0.656 | 0.059 | Sphingosine 1-phosphate receptor 3 antagonist | 0.059 0.039 DBMET03284 0.058 0.041 DBMET00651 0.055 0.046 DBMET03283 | DBMET03284 | |
| 0.004 | 0.658 | 0.071 | Carbamoyl phosphate synthetase inhibitor | 0.066 0.038 DBMET00651 0.071 0.034 DBMET03282 | DBMET03282 | |
| 0.002 | 0.659 | 0.045 | 5-Alpha-reductase inhibitor | 0.045 0.021 DBMET03282 | DBMET03282 | |
| 0.044 | 0.705 | 0.254 | Lipocortins synthesis antagonist | 0.198 0.058 DBMET02408 0.254 0.032 DBMET03282 | DBMET03282 | |
| 0.003 | 0.667 | 0.109 | Phosphofructokinase-1 inhibitor | 0.102 0.031 DBMET00651 0.109 0.028 DBMET03282 0.095 0.034 DBMET03283 | DBMET03282 | |
| 0.002 | 0.67 | 0.042 | Geranyltranstransferase inhibitor | 0.042 0.034 DBMET00651 | DBMET00651 | |
| 0.013 | 0.684 | 0.073 | Glycine receptor agonist | 0.066 0.064 DB06701 0.073 0.049 DBMET00651 0.068 0.06 DBMET03283 | DBMET00651 | |
| 0.004 | 0.678 | 0.073 | Acetylcholine M5 receptor agonist | 0.073 0.04 DBMET03284 | DBMET03284 | |
| 0.014 | 0.693 | 0.133 | DOPA decarboxylase inhibitor | 0.1 0.076 DBMET00651 0.132 0.033 DBMET02407 0.102 0.073 DBMET03282 0.133 0.033 DBMET03283 | DBMET03283 | |
| 0.011 | 0.698 | 0.077 | Keratolytic | 0.077 0.054 DBMET03283 | DBMET03283 | |
| 0.008 | 0.697 | 0.177 | Cystathionine beta-synthase inhibitor | 0.094 0.085 DB06701 0.111 0.065 DBMET00651 0.113 0.064 DBMET02408 0.177 0.031 DBMET02407 0.134 0.049 DBMET03282 0.176 0.031 DBMET03283 | DBMET02407 | |
| 0.012 | 0.703 | 0.175 | Neuropeptide Y1 antagonist | 0.173 0.036 DB06701 0.171 0.038 DBMET03284 0.149 0.066 DBMET00651 0.156 0.056 DBMET02408 0.175 0.034 DBMET02407 0.129 0.102 DBMET03282 0.157 0.055 DBMET03283 | DBMET02407 | |
| 0.015 | 0.707 | 0.122 | HIV-1 integrase (Overall Integration) inhibitor | 0.122 0.038 DBMET00651 0.09 0.064 DBMET03282 0.116 0.042 DBMET03283 | DBMET00651 | |
| 0.023 | 0.721 | 0.14 | Transcription factor STAT6 inhibitor | 0.104 0.096 DB06701 0.114 0.071 DBMET03284 0.133 0.04 DBMET00651 0.11 0.08 DBMET02407 0.14 0.032 DBMET03283 | DBMET03283 | |
| 0 | 0.701 | 0.007 | Integrin alpha5beta6 antagonist | 0.007 0.004 DBMET00651 | DBMET00651 | |
| 0.001 | 0.704 | 0.032 | Nicotinic alpha3beta4 receptor agonist | 0.032 0.018 DB06701 0.027 0.026 DBMET00651 | DB06701 | |
| 0.038 | 0.742 | 0.128 | MAP kinase kinase 4 inhibitor | 0.128 0.122 DBMET03283 | DBMET03283 | |
| 0.026 | 0.732 | 0.423 | Superoxide dismutase inhibitor | 0.244 0.078 DB06701 0.263 0.067 DBMET03284 0.376 0.031 DBMET00651 0.297 0.051 DBMET02407 0.211 0.105 DBMET03282 0.423 0.023 DBMET03283 | DBMET03283 | |
| 0.003 | 0.709 | 0.072 | NMDA receptor glycine site agonist | 0.057 0.049 DBMET00651 0.072 0.035 DBMET03282 | DBMET03282 | |
| 0.013 | 0.723 | 0.173 | Electrolyte absorption antagonist | 0.108 0.047 DB06701 0.095 0.065 DBMET03284 0.151 0.019 DBMET00651 0.125 0.033 DBMET02408 0.085 0.084 DBMET02407 0.173 0.013 DBMET03282 0.113 0.042 DBMET03283 | DBMET03282 | |
| 0.014 | 0.724 | 0.073 | Vanilloid 4 agonist | 0.073 0.056 DBMET00651 | DBMET00651 | |
| 0.005 | 0.717 | 0.205 | Diuretic | 0.138 0.087 DBMET03284 0.136 0.089 DBMET00651 0.132 0.093 DBMET02408 0.205 0.042 DBMET03282 | DBMET03282 | |
| 0.015 | 0.727 | 0.182 | Sphingosine 1-phosphate receptor 5 antagonist | 0.132 0.095 DB06701 0.162 0.044 DBMET03284 0.182 0.022 DBMET00651 0.129 0.102 DBMET02407 0.146 0.069 DBMET03282 0.172 0.031 DBMET03283 | DBMET00651 | |
| 0.017 | 0.729 | 0.135 | Cyclooxygenase 3 inhibitor | 0.114 0.084 DBMET03284 0.118 0.08 DBMET00651 0.113 0.086 DBMET02407 0.135 0.062 DBMET03283 | DBMET03283 | |
| 0.011 | 0.726 | 0.109 | Cathepsin H inhibitor | 0.109 0.09 DBMET00651 0.103 0.101 DBMET03282 | DBMET00651 | |
| 0.003 | 0.718 | 0.067 | Dopamine D2 antagonist | 0.067 0.045 DB06701 0.058 0.051 DBMET02407 | DB06701 | |
| 0.003 | 0.718 | 0.039 | Dipeptidyl peptidase II inhibitor | 0.039 0.015 DBMET00651 | DBMET00651 | |
| 0.008 | 0.724 | 0.283 | Calpain 2 inhibitor | 0.283 0.126 DBMET03284 0.234 0.161 DBMET02408 0.227 0.166 DBMET03282 | DBMET03284 | |
| 0.007 | 0.723 | 0.043 | Glucose-6-phosphate isomerase inhibitor | 0.043 0.042 DBMET03282 | DBMET03282 | |
| 0.003 | 0.722 | 0.161 | Alpha adrenoreceptor agonist | 0.161 0.014 DB06701 0.095 0.03 DBMET03284 0.094 0.03 DBMET00651 0.143 0.017 DBMET02407 0.095 0.03 DBMET03283 | DB06701 | |
| 0.004 | 0.724 | 0.081 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.081 0.051 DBMET02407 | DBMET02407 | |
| 0.006 | 0.729 | 0.37 | Anesthetic general | 0.272 0.041 DB06701 0.37 0.021 DBMET03284 0.271 0.042 DBMET00651 0.33 0.027 DBMET02408 0.293 0.035 DBMET02407 0.328 0.027 DBMET03282 0.269 0.043 DBMET03283 | DBMET03284 | |
| 0.003 | 0.726 | 0.072 | Alcohol oxidase inhibitor | 0.056 0.039 DBMET03282 0.072 0.028 DBMET03283 | DBMET03283 | |
| 0.013 | 0.737 | 0.15 | Triose-phosphate isomerase inhibitor | 0.12 0.032 DBMET00651 0.15 0.02 DBMET03282 0.099 0.048 DBMET03283 | DBMET03282 | |
| 0.014 | 0.74 | 0.192 | Adenylate cyclase stimulant | 0.148 0.066 DB06701 0.168 0.038 DBMET03284 0.178 0.027 DBMET00651 0.169 0.037 DBMET02407 0.143 0.075 DBMET03282 0.192 0.017 DBMET03283 | DBMET03283 | |
| 0.012 | 0.738 | 0.198 | Succinate dehydrogenase inhibitor | 0.156 0.102 DBMET03284 0.183 0.065 DBMET00651 0.198 0.05 DBMET03282 0.177 0.071 DBMET03283 | DBMET03282 | |
| 0.008 | 0.735 | 0.091 | Ornithine decarboxylase inhibitor | 0.091 0.055 DBMET03284 | DBMET03284 | |
| 0.004 | 0.733 | 0.067 | Beta 2 adrenoreceptor agonist | 0.062 0.04 DBMET02407 0.067 0.026 DBMET03283 | DBMET03283 | |
| 0.001 | 0.735 | 0.042 | Free fatty acid receptor 1 antagonist | 0.042 0.014 DBMET00651 0.036 0.02 DBMET03282 | DBMET00651 | |
| 0.003 | 0.737 | 0.08 | Glutamate (mGluR3) antagonist | 0.066 0.007 DBMET00651 0.033 0.032 DBMET02408 0.08 0.005 DBMET03282 0.051 0.012 DBMET03283 | DBMET03282 | |
| 0.003 | 0.738 | 0.231 | NMDA receptor antagonist | 0.08 0.065 DB06701 0.082 0.063 DBMET03284 0.17 0.019 DBMET00651 0.131 0.031 DBMET02407 0.108 0.042 DBMET03282 0.231 0.011 DBMET03283 | DBMET03283 | |
| 0.004 | 0.739 | 0.108 | Phenylalanine 4-hydroxylase inhibitor | 0.083 0.035 DBMET00651 0.083 0.035 DBMET03282 0.108 0.022 DBMET03283 | DBMET03283 | |
| 0.004 | 0.739 | 0.114 | Glutamate decarboxylase inhibitor | 0.091 0.035 DBMET00651 0.082 0.042 DBMET03282 0.114 0.023 DBMET03283 | DBMET03283 | |
| 0.019 | 0.755 | 0.309 | Cholesterol antagonist | 0.208 0.158 DB06701 0.309 0.086 DBMET03284 0.268 0.113 DBMET00651 0.235 0.136 DBMET02408 0.273 0.109 DBMET02407 0.292 0.096 DBMET03282 0.298 0.092 DBMET03283 | DBMET03284 | |
| 0.006 | 0.744 | 0.129 | Calcium antagonist | 0.115 0.038 DB06701 0.129 0.03 DBMET03284 | DBMET03284 | |
| 0.003 | 0.744 | 0.066 | Dopamine antagonist | 0.066 0.057 DB06701 | DB06701 | |
| 0.008 | 0.749 | 0.469 | GABA C receptor agonist | 0.169 0.027 DB06701 0.114 0.054 DBMET03284 0.469 0.004 DBMET00651 0.106 0.061 DBMET02408 0.162 0.03 DBMET02407 0.315 0.008 DBMET03282 0.389 0.005 DBMET03283 | DBMET00651 | |
| 0.008 | 0.752 | 0.101 | Glutamate (mGluR4) antagonist | 0.044 0.03 DB06701 0.084 0.008 DBMET03284 0.101 0.005 DBMET00651 0.068 0.011 DBMET03282 0.064 0.012 DBMET03283 | DBMET00651 | |
| 0.004 | 0.752 | 0.074 | Histidine decarboxylase inhibitor | 0.068 0.053 DBMET02407 0.074 0.047 DBMET03283 | DBMET03283 | |
| 0.011 | 0.76 | 0.281 | 5 Hydroxytryptamine 1E antagonist | 0.281 0.044 DB06701 0.199 0.132 DBMET03284 0.241 0.085 DBMET00651 0.231 0.096 DBMET02408 0.274 0.05 DBMET02407 0.171 0.164 DBMET03282 0.25 0.074 DBMET03283 | DB06701 | |
| 0.006 | 0.758 | 0.143 | Sphingosine 1-phosphate receptor 2 antagonist | 0.132 0.071 DBMET03284 0.143 0.05 DBMET00651 0.138 0.059 DBMET03283 | DBMET00651 | |
| 0.046 | 0.804 | 0.137 | Heat shock protein 70 antagonist | 0.137 0.087 DBMET02407 0.135 0.098 DBMET03283 | DBMET02407 | |
| 0.018 | 0.776 | 0.095 | Glutamate (mGluR7) agonist | 0.089 0.087 DB06701 0.091 0.08 DBMET00651 0.092 0.078 DBMET02408 0.095 0.071 DBMET03282 | DBMET03282 | |
| 0.003 | 0.765 | 0.094 | Argininosuccinate synthase inhibitor | 0.083 0.024 DBMET00651 0.094 0.021 DBMET03282 0.059 0.037 DBMET03283 | DBMET03282 | |
| 0.01 | 0.772 | 0.151 | Non-steroidal antiinflammatory agent | 0.142 0.127 DB06701 0.15 0.114 DBMET03284 0.147 0.119 DBMET02408 0.151 0.114 DBMET02407 | DBMET02407 | |
| 0.005 | 0.768 | 0.081 | GABA aminotransferase inhibitor | 0.07 0.062 DBMET00651 0.069 0.063 DBMET02407 0.081 0.045 DBMET03282 0.077 0.05 DBMET03283 | DBMET03282 | |
| 0.029 | 0.792 | 0.42 | 5 Hydroxytryptamine release inhibitor | 0.295 0.171 DB06701 0.42 0.066 DBMET03284 0.358 0.109 DBMET00651 0.334 0.129 DBMET02408 0.317 0.146 DBMET02407 0.399 0.079 DBMET03282 0.366 0.102 DBMET03283 | DBMET03284 | |
| 0.011 | 0.781 | 0.169 | Cell wall synthesis inhibitor | 0.134 0.082 DBMET00651 0.169 0.049 DBMET03282 0.137 0.079 DBMET03283 | DBMET03282 | |
| 0.005 | 0.783 | 0.065 | Carbonic anhydrase stimulant | 0.065 0.036 DBMET00651 | DBMET00651 | |
| 0.004 | 0.783 | 0.059 | Acetylcholine M5 receptor antagonist | 0.055 0.05 DB06701 0.059 0.043 DBMET03284 0.056 0.048 DBMET00651 | DBMET03284 | |
| 0.013 | 0.793 | 0.197 | Transcription factor STAT inhibitor | 0.197 0.142 DBMET02407 | DBMET02407 | |
| 0.021 | 0.802 | 0.403 | Interleukin agonist | 0.18 0.139 DB06701 0.245 0.083 DBMET03284 0.277 0.06 DBMET00651 0.304 0.046 DBMET02408 0.169 0.15 DBMET02407 0.403 0.018 DBMET03282 0.258 0.073 DBMET03283 | DBMET03282 | |
| 0.007 | 0.788 | 0.095 | Histamine N-methyltransferase inhibitor | 0.095 0.051 DBMET00651 0.092 0.054 DBMET03283 | DBMET00651 | |
| 0.025 | 0.807 | 0.101 | CC chemokine 5 receptor agonist | 0.088 0.04 DB06701 0.078 0.072 DBMET03284 0.092 0.033 DBMET00651 0.091 0.036 DBMET02408 0.096 0.027 DBMET02407 0.095 0.029 DBMET03282 0.101 0.021 DBMET03283 | DBMET03283 | |
| 0.002 | 0.786 | 0.042 | AMPA 3 receptor antagonist | 0.042 0.012 DBMET00651 0.029 0.021 DBMET03283 | DBMET00651 | |
| 0.031 | 0.815 | 0.144 | Ca2+-transporting ATPase inhibitor | 0.131 0.112 DB06701 0.139 0.076 DBMET03284 0.144 0.059 DBMET00651 0.131 0.116 DBMET02408 0.131 0.116 DBMET02407 0.143 0.061 DBMET03282 0.14 0.074 DBMET03283 | DBMET00651 | |
| 0.009 | 0.799 | 0.131 | Adenylate cyclase inhibitor | 0.131 0.058 DBMET03282 0.102 0.082 DBMET03283 | DBMET03282 | |
| 0.006 | 0.797 | 0.121 | Estrogen antagonist | 0.114 0.066 DBMET02407 0.121 0.054 DBMET03283 | DBMET03283 | |
| 0.005 | 0.796 | 0.037 | Glutamate (mGluR8) agonist | 0.037 0.029 DBMET00651 0.037 0.028 DBMET03282 | DBMET03282 | |
| 0.055 | 0.846 | 0.183 | 5 Hydroxytryptamine 3E antagonist | 0.168 0.143 DB06701 0.183 0.099 DBMET03284 0.166 0.151 DBMET00651 | DBMET03284 | |
| 0.001 | 0.793 | 0.034 | Kainate receptor 1 antagonist | 0.034 0.009 DBMET00651 0.018 0.017 DBMET03282 0.018 0.017 DBMET03283 | DBMET00651 | |
| 0.001 | 0.795 | 0.072 | Kainate receptor 2 antagonist | 0.072 0.008 DBMET00651 0.046 0.018 DBMET03282 0.039 0.023 DBMET03283 | DBMET00651 | |
| 0.004 | 0.801 | 0.084 | Glutamate (mGluR7) antagonist | 0.062 0.059 DB06701 0.08 0.028 DBMET00651 0.066 0.05 DBMET02408 0.084 0.023 DBMET03282 0.073 0.037 DBMET03283 | DBMET03282 | |
| 0.005 | 0.802 | 0.102 | Glutamate (mGluR group III) antagonist | 0.047 0.025 DB06701 0.076 0.008 DBMET03284 0.098 0.005 DBMET00651 0.048 0.023 DBMET02408 0.102 0.005 DBMET03282 0.064 0.011 DBMET03283 | DBMET03282 | |
| 0.002 | 0.802 | 0.076 | Biliverdin reductase inhibitor | 0.057 0.044 DBMET00651 0.076 0.028 DBMET03282 | DBMET03282 | |
| 0.005 | 0.805 | 0.107 | Estrogen receptor beta antagonist | 0.103 0.058 DBMET02407 0.107 0.051 DBMET03283 | DBMET03283 | |
| 0.018 | 0.819 | 0.258 | Gastrin inhibitor | 0.221 0.117 DB06701 0.221 0.117 DBMET03284 0.258 0.07 DBMET00651 0.21 0.134 DBMET02408 0.248 0.082 DBMET03282 0.199 0.151 DBMET03283 | DBMET00651 | |
| 0.003 | 0.81 | 0.053 | Beta 2 adrenoreceptor antagonist | 0.048 0.039 DBMET02407 0.053 0.032 DBMET03283 | DBMET03283 | |
| 0.007 | 0.814 | 0.128 | GABA C receptor rho-1 antagonist | 0.103 0.058 DB06701 0.104 0.057 DBMET03284 0.128 0.033 DBMET00651 0.093 0.073 DBMET02407 0.096 0.068 DBMET03282 0.109 0.051 DBMET03283 | DBMET00651 | |
| 0.012 | 0.82 | 0.143 | GABA C receptor rho-2 antagonist | 0.136 0.095 DB06701 0.143 0.084 DBMET03284 0.129 0.107 DBMET02407 | DBMET03284 | |
| 0.002 | 0.81 | 0.089 | NMDA 2A receptor antagonist | 0.071 0.024 DBMET00651 0.047 0.04 DBMET02407 0.089 0.016 DBMET03283 | DBMET03283 | |
| 0.003 | 0.812 | 0.066 | Beta adrenoreceptor antagonist | 0.066 0.045 DBMET02407 0.065 0.046 DBMET03283 | DBMET02407 | |
| 0.014 | 0.823 | 0.166 | Phospholipase C inhibitor | 0.151 0.103 DBMET00651 0.15 0.105 DBMET02407 0.151 0.103 DBMET03282 0.166 0.079 DBMET03283 | DBMET03283 | |
| 0.004 | 0.815 | 0.107 | 5-Lipoxygenase inhibitor | 0.085 0.076 DBMET03282 0.107 0.058 DBMET03283 | DBMET03283 | |
| 0.032 | 0.843 | 0.443 | Calcium channel activator | 0.395 0.026 DB06701 0.387 0.03 DBMET03284 0.356 0.046 DBMET00651 0.443 0.012 DBMET02408 0.38 0.033 DBMET02407 0.406 0.022 DBMET03282 0.346 0.052 DBMET03283 | DBMET02408 | |
| 0.002 | 0.815 | 0.16 | NMDA receptor subunit 3B antagonist | 0.118 0.009 DBMET00651 0.054 0.022 DBMET02407 0.052 0.024 DBMET03282 0.16 0.005 DBMET03283 | DBMET03283 | |
| 0.012 | 0.826 | 0.187 | Neurotrophic factor enhancer | 0.146 0.143 DBMET00651 0.187 0.09 DBMET03283 | DBMET03283 | |
| 0.006 | 0.82 | 0.103 | UDP-glucose 4-epimerase inhibitor | 0.087 0.077 DBMET03284 0.103 0.058 DBMET03282 | DBMET03282 | |
| 0.01 | 0.828 | 0.186 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.135 0.032 DBMET00651 0.083 0.076 DBMET02408 0.186 0.018 DBMET03282 0.1 0.054 DBMET03283 | DBMET03282 | |
| 0.001 | 0.821 | 0.144 | NMDA receptor subunit 3A antagonist | 0.033 0.032 DB06701 0.113 0.007 DBMET00651 0.067 0.015 DBMET02407 0.042 0.024 DBMET03282 0.144 0.005 DBMET03283 | DBMET03283 | |
| 0.012 | 0.833 | 0.178 | Peroxidase inhibitor | 0.111 0.11 DBMET03282 0.178 0.066 DBMET03283 | DBMET03283 | |
| 0.008 | 0.83 | 0.087 | Glutamate dehydrogenase inhibitor | 0.079 0.046 DBMET00651 0.087 0.038 DBMET03282 0.067 0.061 DBMET03283 | DBMET03282 | |
| 0.001 | 0.827 | 0.07 | Kainate receptor antagonist | 0.07 0.012 DBMET00651 0.047 0.023 DBMET03282 0.051 0.021 DBMET03283 | DBMET00651 | |
| 0.005 | 0.835 | 0.134 | Arachidonic acid antagonist | 0.125 0.119 DBMET00651 0.131 0.111 DBMET03282 0.134 0.107 DBMET03283 | DBMET03283 | |
| 0.009 | 0.839 | 0.086 | Bile acid receptor antagonist | 0.086 0.083 DBMET03283 | DBMET03283 | |
| 0.002 | 0.833 | 0.075 | Androgen agonist | 0.064 0.036 DBMET00651 0.058 0.043 DBMET02407 0.059 0.043 DBMET03282 0.075 0.027 DBMET03283 | DBMET03283 | |
| 0.02 | 0.855 | 0.349 | Histamine release inhibitor | 0.321 0.113 DBMET03284 0.267 0.143 DBMET00651 0.349 0.1 DBMET03282 0.314 0.117 DBMET03283 | DBMET03282 | |
| 0.015 | 0.851 | 0.147 | Interferon gamma antagonist | 0.125 0.122 DBMET00651 0.135 0.1 DBMET02408 0.147 0.082 DBMET02407 0.139 0.094 DBMET03282 0.142 0.089 DBMET03283 | DBMET02407 | |
| 0.002 | 0.839 | 0.06 | AMPA 4 receptor antagonist | 0.06 0.01 DBMET00651 0.042 0.023 DBMET03282 0.05 0.015 DBMET03283 | DBMET00651 | |
| 0.039 | 0.882 | 0.348 | 5 Hydroxytryptamine uptake stimulant | 0.294 0.048 DB06701 0.248 0.083 DBMET03284 0.348 0.026 DBMET00651 0.225 0.11 DBMET02408 0.285 0.053 DBMET02407 0.265 0.067 DBMET03282 0.342 0.028 DBMET03283 | DBMET00651 | |
| 0.009 | 0.852 | 0.277 | Aldehyde oxidase inhibitor | 0.173 0.121 DBMET00651 0.156 0.134 DBMET02407 0.277 0.073 DBMET03283 | DBMET03283 | |
| 0.008 | 0.853 | 0.058 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.052 DBMET02408 | DBMET02408 | |
| 0.04 | 0.887 | 0.297 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.288 0.23 DBMET00651 0.297 0.217 DBMET03282 | DBMET03282 | |
| 0.002 | 0.852 | 0.094 | NMDA 2C receptor antagonist | 0.084 0.023 DBMET00651 0.063 0.041 DBMET03282 0.094 0.018 DBMET03283 | DBMET03283 | |
| 0.004 | 0.859 | 0.064 | Beta 3 adrenoreceptor antagonist | 0.064 0.046 DBMET03283 | DBMET03283 | |
| 0.008 | 0.865 | 0.097 | Anabolic | 0.097 0.067 DBMET03282 0.092 0.075 DBMET03283 | DBMET03282 | |
| 0.031 | 0.889 | 0.59 | 5 Hydroxytryptamine release stimulant | 0.356 0.055 DB06701 0.59 0.015 DBMET03284 0.433 0.039 DBMET00651 0.359 0.054 DBMET02407 0.44 0.038 DBMET03283 | DBMET03284 | |
| 0.002 | 0.862 | 0.047 | Histamine agonist | 0.047 0.046 DB06701 0.047 0.046 DBMET00651 | DBMET00651 | |
| 0.003 | 0.865 | 0.095 | Inducible nitric-oxide synthase inhibitor | 0.083 0.056 DB06701 0.095 0.041 DBMET00651 0.081 0.06 DBMET03283 | DBMET00651 | |
| 0.002 | 0.865 | 0.049 | GABA B receptor antagonist | 0.049 0.021 DBMET03284 0.048 0.022 DBMET00651 0.041 0.034 DBMET03283 | DBMET03284 | |
| 0.013 | 0.878 | 0.221 | Amylase inhibitor | 0.103 0.094 DBMET03284 0.15 0.064 DBMET00651 0.144 0.067 DBMET02407 0.116 0.084 DBMET03282 0.221 0.037 DBMET03283 | DBMET03283 | |
| 0.001 | 0.867 | 0.08 | Dopamine D5 agonist | 0.054 0.014 DBMET00651 0.061 0.011 DBMET02407 0.08 0.006 DBMET03283 | DBMET03283 | |
| 0.002 | 0.868 | 0.087 | Porphobilinogen synthase inhibitor | 0.076 0.05 DBMET00651 0.087 0.043 DBMET03282 0.085 0.044 DBMET03283 | DBMET03282 | |
| 0.009 | 0.881 | 0.085 | NADH dehydrogenase inhibitor | 0.079 0.078 DBMET00651 0.085 0.064 DBMET03282 | DBMET03282 | |
| 0.013 | 0.889 | 0.096 | Adenylate kinase inhibitor | 0.093 0.08 DBMET00651 0.096 0.075 DBMET03282 | DBMET03282 | |
| 0.004 | 0.892 | 0.147 | GABA C receptor antagonist | 0.105 0.071 DB06701 0.115 0.058 DBMET03284 0.147 0.032 DBMET00651 0.102 0.075 DBMET02407 0.105 0.07 DBMET03282 0.132 0.041 DBMET03283 | DBMET00651 | |
| 0.014 | 0.903 | 0.248 | GABA C receptor rho-3 antagonist | 0.248 0.156 DBMET03284 0.222 0.182 DBMET03283 | DBMET03284 | |
| 0.001 | 0.89 | 0.029 | Endothelial nitric-oxide synthase inhibitor | 0.029 0.024 DBMET00651 | DBMET00651 | |
| 0.006 | 0.898 | 0.302 | Cyclic AMP phosphodiesterase inhibitor | 0.172 0.12 DB06701 0.228 0.075 DBMET03284 0.302 0.041 DBMET02408 0.18 0.111 DBMET02407 0.215 0.083 DBMET03282 | DBMET02408 | |
| 0.003 | 0.898 | 0.087 | GABA B receptor agonist | 0.078 0.047 DBMET00651 0.087 0.03 DBMET03283 | DBMET03283 | |
| 0.003 | 0.898 | 0.093 | Nitric-oxide synthase inhibitor | 0.093 0.073 DBMET00651 | DBMET00651 | |
| 0.004 | 0.902 | 0.131 | Creatine kinase inhibitor | 0.084 0.081 DBMET00651 0.131 0.034 DBMET03283 | DBMET03283 | |
| 0.007 | 0.911 | 0.146 | ATPase inhibitor | 0.137 0.126 DB06701 0.146 0.108 DBMET02408 0.142 0.116 DBMET02407 | DBMET02408 | |
| 0.007 | 0.915 | 0.086 | Exportin-1 inhibitor | 0.086 0.018 DBMET03284 | DBMET03284 | |
| 0.001 | 0.915 | 0.021 | Imidazoline I1 receptor antagonist | 0.021 0.014 DB06701 | DB06701 | |
| 0.004 | 0.932 | 0.058 | Dihydroorotate oxidase inhibitor | 0.058 0.032 DBMET03282 | DBMET03282 | |
| 0.002 | 0.937 | 0.198 | Ferrochelatase inhibitor | 0.143 0.041 DBMET00651 0.198 0.023 DBMET03282 | DBMET03282 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |